Clinical Trials Directory

Trials / Unknown

UnknownNCT02127385

The Type of Hepatoglobin in IUGR

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Intra Uterine Growth Restriction is associated with increased oxidative stress. Haptoglobin (Hp) is an abundant plasma glycoprotein produced in the liver. The function of Hp is as anti oxidant agent, it binds free hemoglobin (Hb) released from red blood cells to decrease oxidative tissue damage. There are 3 differenet genotype of haptoglobin Hp 1-1 Hp 1-2 and Hp 2-2 with different anti oxidant properties and different prevalence ( Hp 1-1, Hp 1-2 and Hp 2-2approximately 16%, 48% and 36% respectively) . we hypotheise that IUGR will be more common and severe in the Hp 2-2 genotype with the less anti oxidant properties.

Conditions

Timeline

Start date
2014-04-01
Primary completion
2015-04-01
First posted
2014-04-30
Last updated
2014-04-30

Source: ClinicalTrials.gov record NCT02127385. Inclusion in this directory is not an endorsement.